Update - Zayed National Museum and Bahrain Launch Six-Week Archaeologica… Transport - Dubai RTA Introduces Five-Star Rating System for Taxi Companies… Weather - Rain Expected in Some Areas on November 16 as Temperatures Drop…

Send an Inquiry

Fill in the details below and our team will get back to you.

Healthcare 1 min read 111 views

UAE Ministry of Health and Prevention Issues Circular to Withdraw Brilinta 90 mg Drug with Batch Number JB504 by AstraZeneca

The UAE Ministry of Health and Prevention has provided a round to all medical facilities and medical facilities to take out Brilinta 90 mg set number JB504 by AstraZeneca, with instant impact because of incorrect packaging. The medication, which is used in people with cardiac arrest and stroke, has been withdrawn since the bundle has an additional medicine called Zurampic (Lesinurad) 200mg tablet, likewise made by AstraZeneca.

H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing Field of the UAE Ministry of Health and Prevention, and Chairman of the Supreme National Drug Registration, stated that the US Food and Drug Administration (FDA) has actually released a warning that the maker has willingly withdrawn this set of the product. He claimed that wrong doses of Zurampic could result in renal failure, while abrupt discontinuation of Brilinta could raise the threat of cardiac arrest and stroke. He included that Brilinta has been authorized by the FDA for the prevention of preventing blood clotting to lower events of cardiovascular death and cardiovascular disease in patients with acute coronary syndrome (A/C).

The UAE Ministry of Health and Prevention is in contact with worldwide pharmaceutical companies to circulate any type of caution.

The Assistant Undersecretary clarified that Zurampic is not signed up in the Ministry's Medicine Department; nonetheless, to make sure the safety of individuals, it has been determined to release the round and take the necessary action.

H.E. Dr. Al Amiri stressed that the Ministry remains in routine contact with the FDA and the medicine authorities of Europe and Australia. He stated that if any warning is released pertaining to any kind of medicine, the Ministry promptly takes action and issues a circular to all concerned health authorities to remove these products and destroy them, making certain health and safety of the community.

The public is requested to inform the Ministry of Health and Prevention in case of any side effects from a drug.

If you experience any medicine related side effects, please fill in the ADR Side Results Form which could be downloaded from http://www.cpd-pharma.ae, or contact pv@moh.gov.ae, or get in touch with 971023201448 or fax on 971023201947.

Related News

More on Healthcare

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Business

Big 5 Global 2026: Six French companies to showcase advanced construction technologies in Dubai

Six French companies will present their construction technologies and expertise at Big 5 Global 2026, scheduled to take place from November 23 to 26 at the Dubai World Trade Centre. Supported by Business France, AITENDERS, ALPHI ME, ARIADIS, COMUS, CSTB and QUADRA will showcase solutions across...

Nov 16, 2026 · 3 min
Education

JICE connects UAE students with higher education opportunities in Japan at NAJAH Abu Dhabi 2026

The Japan International Cooperation Center (JICE) welcomed approximately 1,200 visitors to the Japan Pavilion at NAJAH Abu Dhabi 2026, held from October 18 to 21 at ADNEC Centre Abu Dhabi. The initiative introduced students and families to higher education opportunities in Japan through...

Nov 16, 2026 · 2 min
Real Estate

Emirates REIT reports 12% rise in property income as Funds from Operations nearly double in Q3 2026

Emirates REIT (CEIC) PLC reported strong financial results for the nine months ended September 30, 2026, with year-on-year growth in property income, operating profit and Funds from Operations (FFO), alongside improvements in its balance sheet. Equitativa (Dubai) Limited, the manager of Emirates...

Nov 16, 2026 · 2 min
Education

Almasar Alshamil Education outlines vision for future of learning at Education Investment MENA 2026

Almasar Alshamil Education Chief Executive Officer Majed Al Mutairi joined regional education leaders at Education Investment MENA 2026 in Dubai, where discussions focused on the future of learning, the role of technology and the importance of collaboration across the education sector. Held on...

Nov 16, 2026 · 2 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.